Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy

por Wills, Lucy, Maggs, Rhydian, Lewis, Geraint, Jones, Gareth, Nixon, Lisette, Staffurth, John, Crosby, Tom
Publicado 2017

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial

por Fokas, Emmanouil, Spezi, Emiliano, Patel, Neel, Hurt, Chris, Nixon, Lisette, Chu, Kwun-Ye, Staffurth, John, Abrams, Ross, Mukherjee, Somnath
Publicado 2016

Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial

por Fennell, Dean A., Porter, Catharine, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette, Gardner, Georgina, White, Ann, Griffiths, Gareth, Casbard, Angela
Publicado 2022

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

por Hurt, Christopher N, Nixon, Lisette S, Griffiths, Gareth O, Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N, Phillips, Ceri J, Blazeby, Jane M, Crosby, Tom D
Publicado 2011

Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer S...

por Adamson, Douglas, Blazeby, Jane, Nelson, Annmarie, Hurt, Chris, Nixon, Lisette, Fitzgibbon, Jim, Crosby, Tom, Staffurth, John, Evans, Mim, Kelly, Noreen Hopewell, Cohen, David, Griffiths, Gareth, Byrne, Anthony
Publicado 2014

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial

por Adamson, Douglas, Byrne, Anthony, Porter, Catharine, Blazeby, Jane, Griffiths, Gareth, Nelson, Annmarie, Sewell, Bernadette, Jones, Mari, Svobodova, Martina, Fitzsimmons, Deborah, Nixon, Lisette, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John, Hurt, Christopher
Publicado 2021

Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial

por Fennell, Dean A., Porter, Catharine, Lester, Jason, Danson, Sarah, Taylor, Paul, Sheaff, Michael, Rudd, Robin M, Gaba, Aarti, Busacca, Sara, Nixon, Lisette, Gardner, Georgina, Darlison, Liz, Poile, Charlotte, Richards, Cathy, Jordan, Peter-Wells, Griffiths, Gareth, Casbard, Angela
Publicado 2022

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to indu...

por Mukherjee, Somnath, Hurt, Christopher N., Adams, Richard, Bateman, Andrew, Bradley, Kevin M., Bridges, Sarah, Falk, Stephen, Griffiths, Gareth, Gwynne, Sarah, Jones, Christopher M., Markham, Philip J., Maughan, Tim, Nixon, Lisette S., Radhakrishna, Ganesh, Roy, Rajarshi, Schoenbuchner, Simon, Sheikh, Hamid, Spezi, Emiliano, Hawkins, Maria, Crosby, Thomas D.L.
Publicado 2023

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised control...

por Mukherjee, Somnath, Hurt, Christopher, Radhakrishna, Ganesh, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Hawkins, Maria A., Canham, Joanne, Grabsch, Heike I., Falk, Stephen, Sharma, Ricky A., Ray, Ruby, Roy, Rajarshi, Cox, Catrin, Maynard, Nick, Nixon, Lisette, Sebag-Montefiore, David J., Maughan, Timothy, Griffiths, Gareth O., Crosby, Tom D.L.
Publicado 2021